Inventor
GILL ALAN
US14 patents
⚠️ This page may combine multiple inventors who share the name “GILL ALAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALS THERAPY DEVELOPMENT INST
8 patentsUS11692040B2Jul 4, 2023
Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorders
ALS THERAPY DEVELOPMENT INST4 citations82
US11014990B2May 25, 2021
Anti-CD40L antibodies
ALS THERAPY DEVELOPMENT INST6 citations81
US10683356B2Jun 16, 2020
Methods of treating a CD40L associated disease or disorder by administering anti-CD40L antibodies
ALS THERAPY DEVELOPMENT INST8 citations81
US10106618B2Oct 23, 2018
Anti-CD40L antibodies
ALS THERAPY DEVELOPMENT INST8 citations81
US12157728B2Dec 3, 2024
Targeting of endoplasmic reticulum dysfunction and protein folding stress to treat neurological conditions
ALS THERAPY DEVELOPMENT INST0 citations61
US11708349B2Jul 25, 2023
Targeting of endoplasmic reticulum dysfunction and protein folding stress to treat neurological conditions
ALS THERAPY DEVELOPMENT INST1 citations61
US12275793B2Apr 15, 2025
Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorders
ALS THERAPY DEVELOPMENT INST0 citations59
US11660324B2May 30, 2023
Copper complexes for treatment of neurodegenerative disorders
ALS THERAPY DEVELOPMENT INST0 citations56